Efficiency and safety of pharmacological cardioversion for atrial fibrillation
Клинический разбор в общей медицине, 2021 Currently, atrial fibrillation is the most prevalent supraventricular tachycardia. Selection of management strategy for such patients becomes an important issue for medical practitioners.
Aleksei V. Tarasov
doaj +1 more source
Non-valvular atrial fibrillation and stroke : implications for management [PDF]
, 1995 Nonvalvular Atrial Fibrillation is more prevalent with increasing age. It is associated with a six-fold excess risk of stroke; and a cumulative lifetime stroke risk of 35%. 15% of ischaemic strokes are directly attributable to it.
Tilney, Myra Kay
core
Recurring patterns of atrial fibrillation in surface ECG predict restoration of sinus rhythm by catheter ablation [PDF]
, 2014 Background Non-invasive tools to help identify patients likely to benefit from catheter ablation (CA) of atrial fibrillation (AF) would facilitate personalised treatment planning.
Bourke, John P. +3 more
core +1 more source
Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
Upsala Journal of Medical Sciences, 2017 Background: Sleep apnea is common in patients with atrial fibrillation, but the effect of the cardioversion of atrial fibrillation to sinus rhythm on central and obstructive apneas is mainly unknown.
Niklas Höglund +4 more
doaj +1 more source
Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018 Background Antazoline mesylate represents an antihistamine capable of rapid and safe cardioversion of atrial fibrillation, yet evidence concerning its efficacy in comparison to other medications is insufficient.
Maciej T. Wybraniec +5 more
doaj +1 more source
Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients. results from the BACH Study (Biomarkers in ACute Heart Failure) [PDF]
, 2013 Objectives: The purpose of this study was to assess the impact of atrial fibrillation (AF) on the performance of mid-region amino terminal pro-atrial natriuretic peptide (MR-proANP) in comparison with the B-type peptides (BNP and NT-proBNP) for diagnosis
Anand I +19 more
core +1 more source
Pharmacological cardioversion for atrial fibrillation and flutter* [PDF]
, 2006 Atrial fibrillation is the commonest cardiac dysrhythmia. It is associated with significant morbidity and mortality. There are two approaches to the management of atrial fibrillation: controlling the ventricular rate or converting to sinus rhythm in ...
Cordina, J, Mead, G
core
Managing atrial fibrillation in the global community: The European perspective. [PDF]
, 2013 Atrial fibrillation is a common, global problem, with great personal, economic and social burdens. As populations age it increases in prevalence and becomes another condition that requires careful chronic management to ensure its effects are minimised ...
Camm, AJ +3 more
core +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017 Background Several different defibrillators are currently used for cardioversion and defibrillation of cardiac arrhythmias. The efficacy of a novel pulsed biphasic (PB) waveform has not been compared to other biphasic waveforms.
Anders S. Schmidt +9 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Electrical cardioversion (ECV) is routinely used to restore sinus rhythm in patients with symptomatic atrial fibrillation. The European guidelines have been updated in recent years.
Tomas Forslund +3 more
doaj +1 more source